A novel SERPINA12 variant and first European patients with diffuse palmoplantar keratoderma
Journal of the European Academy of Dermatology and Venereology · 2024
DOI: 10.1111/jdv.19498 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of the European Academy of Dermatology and Venereology, 2024. Verfasst von E Brandt und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology and Allergology, ERN-Skin Center, University of Helsinki and Helsinki University Central Hospital, Helsinki, Finland. Hauptthemen laut MEDLINE: Keratoderma, Palmoplantar, Hyperhidrosis, Serpins. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 18 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Emil Aaltonen Foundation, Helsinki University Hospital, Jane ja Aatos Erkko Foundation.
Abstract (Originalsprache)
Background
Hereditary palmoplantar keratodermas (hPPKs) comprise a heterogeneous group of skin disorders characterized by persistent palmoplantar hyperkeratosis. Loss‐of‐function variants in a serine peptidase inhibitor, SERPINA12 , have recently been implicated in autosomal recessive diffuse hPPK. The disorder appears to share similarities with another hPPK associated with protease overactivity, namely Nagashima‐type PPK (NPPK) caused by biallelic variants in SERPINB7 .
Objectives
The aim of this study was to enhance the understanding of the clinical and genetic characteristics of serine protease‐related hPPKs caused by variants in SERPINA12 and SERPINB7 .
Methods
Whole‐exome sequencing (WES) was performed for hPPK patients. Haplotype analysis was completed for the patients with identified recessive SERPINA12 variants and their available family members. In addition, the current literature of SERPINA12 ‐ and SERPINB7 ‐related hPPKs was summarized.
Results
The phenotype of SERPINA12 ‐related hPPK was confirmed by reporting three new SERPINA12 patients, the first of European origin. A novel SERPINA12 c.1100G>A p.(Gly367Glu) missense variant was identified confirming that the variant spectrum of SERPINA12 include both truncating and missense variants. The previously reported SERPINA12 c.631C>T p.(Arg211*) was indicated enriched in the Finnish population due to a plausible founder effect. In addition, SERPINA12 hPPK patients were shown to share a similar phenotype to patients with recessive variants in SERPINB7 . The shared phenotype included diffuse transgradient PPK since birth or early childhood and frequent palmoplantar hyperhidrosis, aquagenic whitening and additional hyperkeratotic lesions in non‐palmoplantar areas. SERPINA12 and SERPINB7 hPPK patients cannot be distinguished without genetic analysis.
Conclusions
Recessive variants in SERPINA12 and SERPINB7 leading to protease overactivity and hPPK produce a similar phenotype, indistinguishable without genetic analysis. SERPINA12 variants should be assessed also in non‐Asian patients with diffuse transgradient PPK. Understanding the role of serine protease inhibitors will provide insights into the complex proteolytic network in epidermal homeostasis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Dermatology and Allergology, ERN-Skin Center, University of Helsinki and Helsinki University Central Hospital, Helsinki, Finland.
- Folkhälsan Research Center, Helsinki, Finland and Research Programs Unit, Stem Cells and Metabolism Research Program, University of Helsinki, Helsinki, Finland.
- Institute for Molecular Medicine Finland (FIMM), Helsinki Institute of Life Science (HiLIFE), University of Helsinki, Helsinki, Finland.
- The Centre for Molecular Medicine Norway (NCMM), University of Oslo, Oslo, Norway.
- Department of Clinical Genetics and Department of Medical and Clinical Genetics, University of Helsinki and Helsinki University Central Hospital, Helsinki, Finland.
- Department of Biosciences and Nutrition, Karolinska Institutet, Huddinge, Sweden.
Förderung
- Emil Aaltonen Foundation
- Helsinki University Hospital
- Jane ja Aatos Erkko Foundation
- Sigrid Jusélius Foundation
- Finnish Dermatological Society
- Finnish Cultural Foundation
- Finnish Medical Foundation
- Swedish Psoriasis Foundation
Zitieren
APA
Brandt, E., Harjama, L., Elomaa, O., Saarela, J., Donner, K., Lappalainen, K., Kivirikko, S., Ranki, A., Kere, J., Kettunen, K., & Hannula-Jouppi, K. (2024). A novel SERPINA12 variant and first European patients with diffuse palmoplantar keratoderma. Journal of the European Academy of Dermatology and Venereology. https://doi.org/10.1111/jdv.19498
Vancouver
Brandt E, Harjama L, Elomaa O, Saarela J, Donner K, Lappalainen K, et al. A novel SERPINA12 variant and first European patients with diffuse palmoplantar keratoderma. Journal of the European Academy of Dermatology and Venereology. 2024. doi:10.1111/jdv.19498
BibTeX
@article{Brandt2024,
author = {Brandt, E and Harjama, L and Elomaa, O and Saarela, J and Donner, K and Lappalainen, K and Kivirikko, S and Ranki, A and Kere, J and Kettunen, K and Hannula-Jouppi, K},
title = {A novel SERPINA12 variant and first European patients with diffuse palmoplantar keratoderma},
journal = {Journal of the European Academy of Dermatology and Venereology},
year = {2024},
doi = {10.1111/jdv.19498}
}
EUVIMED